drugset / Trial / NCT00659321
Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
Phase 3
Completed
68 enrolled
GWT-TUD GmbH
Technische Universität Dresden · collabUniversity of Regensburg · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Placebo controlled evaluation of effectiveness of nicotine acid in treatment of postprandial dyslipidemia in patients with metabolic syndrome. Nicotine acid decreases postprandial hyperlipidaemia in patients with metabolic syndrome which reduces the low-grade inflammation and the risk of atherosclerosis.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-09
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | nicotine acid | Unknown | 1500 mg | — |